Search Results - "Fici, F"

Refine Results
  1. 1
  2. 2

    9C.07: MULTICENTRE RANDOMISED, DOUBLE BLIND, EVALUATION OF NEBIVOLOL PLUS HCTZ AND IRBESARTAN PLUS HCTZ IN THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY: THE NEHIS STUDY by Seravalle, G, Van Bortel, L, Bombelli, M, Dell’Oro, R, Trevano, F Quarti, Dozio, D, Makel, W, Fici, F, Mancia, G, Grassi, G

    Published in Journal of hypertension (01-06-2015)
    “…OBJECTIVE:According to the 2013 ESH/ESC guidelines combination drug treatment is recommended in the treatment of isolated systolic hypertension (ISH) to…”
    Get full text
    Journal Article
  3. 3

    Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up by Fici, F., Seravalle, G., Koylan, N., Nalbantgil, I., Cagla, N., Korkut, Y., Quarti-Trevano, F., Makel, W., Grassi, G.

    “…Introduction Although improved during the past few years, blood pressure control remains sub optimal. Aim The impact of follow-up assessment on blood pressure…”
    Get full text
    Journal Article
  4. 4

    Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study) by ABACI, A, OGUZ, A, KOZAN, O, TOPRAK, N, SENOCAK, H, DEGER, N, SAHIN, M, SUR, H, FICI, F, EROL, C

    Published in Journal of human hypertension (01-05-2006)
    “…Although the management and the control rates of hypertension are generally low throughout the world, there are substantial differences between the countries…”
    Get full text
    Journal Article
  5. 5

    Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients by Cleophas, T J, Agrawal, R, Lichtenthal, A, Mäkel, W, Fici, F

    Published in American journal of therapeutics (01-05-2006)
    “…Nebivolol has been adequately tested in clinical efficacy trials of patients with mild hypertension. Clinical efficacy trials or their meta-analyses did not…”
    Get full text
    Journal Article
  6. 6

    Genetic polymorphisms and endothelial dysfunction in patients with essential hypertension: a cross-sectional case-control study by Demirel, S, Akkaya, V, Cine, N, Oflaz, H, Yekeler, E, Ozturk, S, Cleophas, T J, Fici, F

    Published in Netherlands heart journal (01-04-2005)
    “…Both in animal models and humans an association between endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphism and the development of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Pulmonary Disposition of Lomefloxacin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. A Multiple-Dose Study by Cazzola, M., Matera, M.G., Tufano, M.A., Catalanotti, P., Polverino, M., Cantoni, V., Fici, F., Sarlo, F., Rossi, F.

    Published in Journal of chemotherapy (Florence) (01-08-2001)
    “…In this study we have measured the concentrations of lomefloxacin at steady state in serum and in the intrapulmonary region at specified intervals for 24 h…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Bioequivalence Assessment of Two Different Tablet Formulations of Diltiazem After Single and Repeated Doses in Healthy Subjects by Loffreda, A., Matera, M. G., Vacca, C., Motola, G., De Santis, D., Ruggiero, A., Russo, F., Fici, F., Cantoni, V., Lampa, E., Rossi, F.

    “…Summary The study was performed on 14 healthy volunteers in order to compare the pharmacokinetics and hence assess the bioequivalence of two different tablet…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Quality of Life and Antihypertensive Effect With Nebivolol and Losartan by Van Bortel, Luc M., Bulpitt, Christopher J., Fici, Francesco

    Published in American journal of hypertension (01-08-2005)
    “…Quality of life and antihypertensive effect, two important therapeutic goals, were determined with the third generation β-blocker nebivolol and the angiotensin…”
    Get full text
    Journal Article
  13. 13

    P-Wave Dispersion and Its Relationship to Aortic Elasticity in Young Prehypertensive Patients by Celik, Turgay, Yuksel, U. Cagdas, Bugan, Baris, Celik, Murat, Fici, Francesco, Iyisoy, Atila, Kilic, Selim, Sonmez, Alper, Yaman, Halil, Isik, Ersoy

    Published in American journal of hypertension (01-12-2009)
    “…Background Prolonged P-wave duration (Pdur) and increased P-wave dispersion (PWD) are independent predictors of atrial fibrillation (AF) in patients with…”
    Get full text
    Journal Article
  14. 14

    PHARMACOLOGY OF NEBIVOLOL by MANGRELLA, MARIO, ROSSI, FRANCESCA, FICI, FRANCESCO, ROSSI, FRANCESCO

    Published in Pharmacological research (01-12-1998)
    “…Nebivolol is a new selective β1-adrenergic blocking agent, that possesses a peculiar pharmacodynamic profile and an original chemical structure, by which it…”
    Get full text
    Journal Article
  15. 15

    A Randomised Comparison of the Effects of Nebivolol and Atenolol with and without Chlorthalidone on the Sexual Function of Hypertensive Men by Boydak, Bahar, Nalbantgil, Sanem, Fici, Francesco, Nalbantgil, Istemi, Zoghi, Mehdi, Ozerkan, Filiz, Tengiz, Istemihan, Ercan, Ertuğrul, Yilmaz, Hasan, Yoket, Umit, Onder, Remzi

    Published in Clinical drug investigation (01-01-2005)
    “…Erectile dysfunction, which is common in men with hypertension, has been reported as a common adverse effect of many antihypertensive drug classes, including…”
    Get full text
    Journal Article
  16. 16

    Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease by LEKAKIS, John P, PROTOGEROU, Athanassios, PAPAMICHAEL, Christos, VAMVAKOU, Georgia, ICONOMIDIS, Ignatios, FICI, Francesco, MAVRIKAKIS, Myron

    Published in Cardiovascular drugs and therapy (01-08-2005)
    “…Endothelial dysfunction is considered to be the first step in atherogenesis as well as a predictor of adverse cardiovascular events in patients with coronary…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Treatment of hyperlactacidemia in cirrhotic patients with pyridoxine-alpha-ketoglutarate (PAK) by Belvisi, A, Matergi, M, Fici, F

    “…After pyridoxine-alpha-ketoglutarate (PAK) was administered to patients with hepatic cirrhosis, the blood level values for lactic acid and ammonia showed a…”
    Get more information
    Journal Article